相关实验视频
Updated: May 16, 2025

06:17
Osteoclast Derivation from Mouse Bone Marrow
Published on: November 6, 2014
24.0K
肌细胞特异增强因子2A通过诱导内分泌素受体A型来增强骨质疏松症中的骨质结晶分化
Yao Jin1, Ying Liu1, Yixia Yang1
1Department of Orthopedics, The First Affiliated Hospital of Harbin Medical University, Harbin, 150006, Heilongjiang, P.R. China.
Biochemical genetics
|May 14, 2025
概括
末端素受体A型 (EDNRA) 驱动骨质疏松症中的骨质损失. 抑制EDNRA或其促进剂MEF2A,可以减少骨质细胞分化,并减轻小鼠骨质疏松症的症状.
科学领域:
- 内分泌学 在内分泌学.
- 骨生物学 骨生物学 骨生物学
- 分子生物学分子生物学
背景情况:
- 末端素受体A型 (EDNRA) 的激活有助于骨质结晶性骨的再吸收.
- 骨质疏松症 (OP) 的特点是骨质减少和骨折风险增加.
- 卵巢切除术 (OVX) 诱导的小鼠表现出类似OP的症状,使它们成为研究的相关模型.
研究的目的:
- 调查EDNRA在强化OVX诱导骨质疏松症中骨质细胞分化中的作用.
- 阐明EDNRA影响骨质疏松症表型的机制.
- 探索针对EDNRA或其骨质疏松症治疗的调节途径的潜力.
主要方法:
- 在体内研究使用OVX诱导的小鼠与骨质疏松症类似的症状.
- 微计算机断层扫描 (微CT) 和组织学分析 (HE,TRAP染色).
- 包括RT-qPCR和免疫阻塞在内的分子分析,以评估基因和蛋白质表达.
- 在体外研究骨髓巨细胞 (BMs) 以评估骨质细胞分化.
主要成果:
- 在骨质疏松症小鼠中,EDNRA的表达很高.
- 通过抑制骨质细胞分化,EDNRA在体内 Knockdown 显著缓解了骨质疏松症表型.
- 在BM中EDNRA的淘汰抑制了关键的骨质结晶性因素 (MMP1,MMP8,RANKL,Nfatc1,Ctsk,C-fos,Trap).
- 肌细胞特异增强因子2A (MEF2A) 被确定为EDNRA的转录促进剂.
- MEF2A沉默显示出抗骨质疏松症的效果,这些效果被EDNRA过度表达逆转.
结论:
- MEF2A通过转录上调EDNRA表达.
- 通过通过EDNRA抑制抑制骨质细胞分化,MEF2A敲击减轻OVX诱导的骨质疏松症的骨损失.
- 准MEF2A-EDNRA通路为骨质疏松症提供了一个潜在的治疗策略.
相关概念视频
Osteoclasts in Bone Remodeling
2.8K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.8K
Regulation of Angiogenesis and Blood Supply
2.5K
Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits. Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
2.5K
Hormones and Bone Tissue
2.5K
The endocrine system produces and secretes hormones, which interact with the skeletal system. These hormones control bone growth, maintain bone once it is formed, and remodel it.
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
Hormones That Influence Osteoblasts and/or Maintain the Matrix
Several hormones are necessary for controlling bone growth and maintaining the bone matrix. The pituitary gland secretes growth hormone (GH), which, as its name implies, controls bone growth. This happens in several ways: first, it triggers chondrocyte...
2.5K
TGF - β Signaling Pathway
7.2K
The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors...
7.2K
Master Transcription Regulators
6.8K
Master transcription regulators are regulatory proteins that are predominantly responsible for regulating the expression of multiple genes. Often these genes work in concert to drive a complex process. Activation of a master transcription regulator can lead to a cascade of transcriptional activation necessary for that outcome. These regulators can directly bind to the regulatory sequences of the various genes involved, or they can indirectly regulate transcription by binding to regulatory...
6.8K
Bone Remodeling
38.0K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.0K

